Laviv (autologous fibroblast cell therapy system) - Precigen, Paragon Biosci
Fibrocell Science: Jefferies Global Healthcare Conference (Fibrocell Science) - Jun 6, 2014 - Anticipated primary data from P2 trial for restrictive burn scars in 2015; Anticipated initiation of P3 trial for restrictive burn scars in 2016; Anticipated initiation of P3 trial for vocal cord scars in 2016 
Anticipated new P3 trial • Anticipated P2 data Fibrosis
http://wsw.com/webcast/jeff82/fcsc/
 
Jun 6, 2014
 
.
 
c00634d7-586e-4427-b5a4-f92edc4278a1.jpg